Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New monitoring program aims to reduce repeat suicide attempts

NCT ID NCT03134885

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study evaluated VigilanS, a program that provides coordinated follow-up care for people in northern France who have survived a suicide attempt. Researchers tracked over 12,000 participants to see if the program reduced repeat attempts and improved care coordination. The goal is to standardize practices and lower suicide rates in the region.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this program could provide a model for reducing repeat suicide attempts through better follow-up care.
What could go wrong
This is an observational evaluation, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

12,989 people

The number who actually took part.

Started

Sep 2016

Finished

Dec 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients leaving in the Nord-Pas de Calais region who survived a suicide attempt and entering in the VigilanS program when they discharge from the hospital

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * leaving in the Nord-Pas de Calais region * entering in the VigilanS program after a suicide attempt Exclusion Criteria: * refusal to enter in the program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicide, attempted are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinic Fleury, Hénin Beaumont

    Hénin-Beaumont, France

  • EPSM, St Venant

    Saint-Venant, France

  • EPSM, Tourcoing

    Tourcoing, France

  • General Hospital, Armentieres

    Armentières, France

  • General Hospital, Arras

    Arras, France

  • General Hospital, Bethune

    Béthune, France

  • General Hospital, Boulogne sur Mer

    Boulogne-sur-Mer, France

  • General Hospital, Calais

    Calais, France

  • General Hospital, Cambrai

    Cambrai, France

  • General Hospital, Denain

    Denain, France

  • General Hospital, Douai

    Douai, France

  • General Hospital, Dunkerque

    Dunkirk, France

  • General Hospital, Fourmies

    Fourmies, France

  • General Hospital, Hazebrouck

    Hazebrouck, France

  • General Hospital, Lens

    Lens, France

  • General Hospital, Montreuil sur Mer

    Montreuil-sur-Mer, France

  • General Hospital, Roubaix

    Roubaix, France

  • General Hospital, Seclin

    Seclin, France

  • General Hospital, St Omer

    Saint-Omer, France

  • General Hospital, Tourcoing

    Tourcoing, France

  • General Hospital, Valenciennes

    Valenciennes, France

  • Genral Hospital, Maubeuge

    Maubeuge, France

  • Lucien Bonnafé Hospital, Roubaix

    Roubaix, France

  • Polyclinic, Henin-Beaumont

    Hénin-Beaumont, France

  • Riaumont's Polyclinic, Liévin

    Liévin, France

  • St Philibert's Hospital, Lomme

    Lomme, France

  • St Vincent's Hospital, Lille

    Lille, Lille, France

  • University Hospital, Lille

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.